Open an account

ITonis

ITNS · OTC

$0.0005+$0.00 (+0.00%)TodayMarket closed ·
Prev close $0.0005

About ITNS

Itonis, Inc. engages in the distribution of its homeopathic anti-nausea product to the medical and pharmaceutical industry. The company is headquartered in Lake Forest, California. The company went IPO on 2007-02-21. The Company’s Pharmaceuticals division to produce and market over the counter and prescription homeopathic preparations to treat both common ailments and chronic diseases. The firm has launched the retails sale of the Emesyl nausea relief product. The firm has identified the market for its Emesyl product line as the general public who suffers from nausea. Emesyl has been available for purchase at https://www.amazon.com/dp/B00U20H3KI and www.Emesyl.com. Its subsidiaries include Itonis Holdings, Inc., Itonis Pharmaceuticals, and Paramount Discoveries, Inc.

Employees
3
Headquarters
Lake Forest, California
Listed
Feb 21, 2007
Sector
Health Care
Industry
Pharmaceuticals
Website
itonisholdings.com

ITNS key statistics

Market cap
761.70K
Price-earnings ratio
0.00
Dividend yield
—
Average volume
570.78K
Volume
430.57K
Open price
$0.0004
High today
$0.0005
Low today
$0.0004
52 Week high
$0.0006
52 Week low
$0.0002

ITonis (ITNS) at a glance

As of Oct 20, 2026, ITonis (ITNS) shares are priced at $0.0005, giving the company a market cap of 761.70K and a price-to-earnings ratio of 0.00.

Today the stock has traded between $0.0004 and $0.0005. The current price is 25.0% above the day's low and 0.0% below its high.

Volume so far is 430.57K shares, below the average of 570.78K shares a day.

Over the past year ITonis has ranged from $0.0002 to $0.0006, and now sits 75% of the way up that range.

Similar companies

Companies in the same industry as ITonis

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.